BioSpace News Archive

AOTI Inc. announced today that since the outbreak of the COVID-19 pandemic it has been focusing all its resources on supporting a growing number of wound care patients being treated at home by its unique multi-modality Topical Wound Oxygen (TWO2) therapy.

Synapse Technologies based in Bonita Springs, FL is enlisting robots and other connected devices in the fight against the COVID-19 pandemic.

Itamar Medical Ltd. (Nasdaq: ITMR) (TASE: ITMR), today announced that it has entered into an agreement with Sleep Data Diagnostics and its virtual-care platform BetterNight and Sleep Data Holdings, a leading provider of home-based positive airway pressure (PAP) services.

GW Pharmaceuticals plc (Nasdaq: GWPH, “GW,” “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid platform, along with its U.S. subsidiary Greenwich Biosciences, Inc., announced today that it has received notification from the United States Drug Enforcement Administration (DEA) confirming that EPIDIOLEX® (cannabidiol) is no longer subject to the Controlled Substances Act (CSA)

New offering helps protect health plans, employers from sudden, one-time claims costs while preserving member access to million-dollar curative gene therapies

NEXVOO®, a global healthcare equipment and PPE provider, announces that it is assisting with the US and global pandemic by expanding its resources to offer additional PPE products into the US.

Medisafe, a leading digital therapeutics companion company providing medication management solutions for patients across the healthcare continuum, today announced the immediate deployment of on-demand and ongoing support for patients worldwide facing new challenges as a result of COVID-19.

Bryn Pharma, LLC (“Bryn” or the “Company”), a privately held pharmaceutical company dedicated to finding a better way for patients and caregivers to treat anaphylaxis through its development of a unique bi-dose nasal epinephrine product, today announced the availability of a poster presenting compelling data from a large, two-part, Phase I clinical study in healthy adults.

BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced that it will continue to prioritize COVID-19 testing for hospital inpatients and critically ill patients around the country.

CareCentrix, the leading provider of home-based and post-acute care (PAC) solutions, happily announces for the second consecutive year that it has been awarded a Top Workplaces 2020 recognition by The Tampa Bay Times.